65 studies found for:    hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
Conditions: Stroke;   Brain Infarction
Intervention: Drug: Eptifibatide
22 Not yet recruiting Improving Anticoagulation Control in VISN 1
Conditions: Anticoagulants;   Atrial Fibrillation;   Venous Thromboembolism
Intervention: Behavioral: Outreach, Education, and Motivational Interviewing
23 Not yet recruiting Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)
Condition: HIV-1 Infection
Intervention: Drug: Telmisartan
24 Recruiting Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Condition: Blood Component Removal
Intervention:
25 Recruiting Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol
Condition: Healthy Volunteers
Intervention:
26 Recruiting Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Condition: HIV Infections
Intervention:
27 Recruiting Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: Gene Transfer
28 Unknown  Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
Conditions: Thrombocytopenia;   Hepatitis C;   HIV Infections
Intervention: Drug: Anti-D
29 Recruiting Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
30 Recruiting Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Tumor Infiltrating Lymphocytes;   Drug: IL-15
31 Recruiting Decitabine for High-Risk Sickle Cell Disease
Conditions: Neutropenia;   Sickle Cell Disease;   Decitabine;   Fetal Hemoglobin
Intervention: Drug: Decitabine
32 Recruiting The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study
Condition: Gonorrhoea
Interventions: Drug: Azithromycin;   Drug: Cefixime
33 Recruiting Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Interventions: Dietary Supplement: Zinc gluconate;   Dietary Supplement: Placebo
34 Recruiting Development of Computer-aided Detection and Diagnosis From Imaging Techniques
Condition: Diagnostic Imaging
Intervention:
35 Recruiting Whole Blood and Blood Component Collection for Research
Condition: Healthy
Intervention:
36 Unknown  Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Sleep Disorder
Interventions: Drug: Eszopiclone;   Other: Placebo
37 Not yet recruiting Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery
Condition: HIV-1 Infection
Intervention: Drug: Isotretinoin
38 Recruiting Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Conditions: Leiomyomatosis;   Kidney Neoplasms
Intervention:
39 Recruiting Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms;   Neoplasms, Urethral;   Ureter Cancer;   Cancer of the Urethra;   Urethral Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Lenalidomide
40 Unknown  Morbidity and Mortality Among Dialysis Patients After Treatment for Depression
Conditions: Depression;   ESRD
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years